Search research articles
Contact Us
Filters
Showing results (1-10 of 149) with videos related to
Page
of 15
Sort By:
The Journal of Investigative Dermatology
|
May 14, 2011
Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
Jürgen C Becker, David Schrama
The Journal of Investigative Dermatology
|
December 14, 2011
Control of central and peripheral tolerance to melanocyte differentiation antigens by GILT
Jürgen C Becker, David Schrama
The Journal of Investigative Dermatology
|
May 16, 2013
The dark side of cyclophosphamide: cyclophosphamide-mediated ablation of regulatory T cells
Jürgen C Becker, David Schrama
Seminars in Immunopathology
|
January 12, 2017
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses
David Schrama, Cathrin Ritter, Jürgen C Becker
Current Opinion in Oncology
|
January 12, 2012
Merkel cell carcinoma: recent insights and new treatment options
David Schrama, Selma Ugurel, Jürgen C Becker
Cancer Immunology, Immunotherapy : CII
|
July 31, 2007
Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister, David Schrama, Jürgen C Becker
Experimental Dermatology
|
April 30, 2009
Molecular pathogenesis of Merkel cell carcinoma
Roland Houben, David Schrama, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 22, 2008
Strategies to optimize the use of targeted agents for tumor therapy
Jürgen C Becker, Selma Ugurel, David Schrama
Cancers
|
January 21, 2023
Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma
Roland Houben, Büke Celikdemir, Thibault Kervarrec, et al.
The Journal of Biological Chemistry
|
February 25, 2011
B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger
Pratap Karki, Xiuju Li, David Schrama, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 149) with videos related to
Sort By:
Page
of 15
The Journal of Investigative Dermatology
|
May 14, 2011
Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
Jürgen C Becker, David Schrama
The Journal of Investigative Dermatology
|
December 14, 2011
Control of central and peripheral tolerance to melanocyte differentiation antigens by GILT
Jürgen C Becker, David Schrama
The Journal of Investigative Dermatology
|
May 16, 2013
The dark side of cyclophosphamide: cyclophosphamide-mediated ablation of regulatory T cells
Jürgen C Becker, David Schrama
Seminars in Immunopathology
|
January 12, 2017
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses
David Schrama, Cathrin Ritter, Jürgen C Becker
Current Opinion in Oncology
|
January 12, 2012
Merkel cell carcinoma: recent insights and new treatment options
David Schrama, Selma Ugurel, Jürgen C Becker
Cancer Immunology, Immunotherapy : CII
|
July 31, 2007
Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister, David Schrama, Jürgen C Becker
Experimental Dermatology
|
April 30, 2009
Molecular pathogenesis of Merkel cell carcinoma
Roland Houben, David Schrama, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 22, 2008
Strategies to optimize the use of targeted agents for tumor therapy
Jürgen C Becker, Selma Ugurel, David Schrama
Cancers
|
January 21, 2023
Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma
Roland Houben, Büke Celikdemir, Thibault Kervarrec, et al.
The Journal of Biological Chemistry
|
February 25, 2011
B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger
Pratap Karki, Xiuju Li, David Schrama, et al.
Page
of 15